Origent Data Sciences has been awarded a Phase 1 Small Business Innovation Research (SBIR) award from the NIH National Center for Advancing Translational Sciences (NCATS). The grant award project, titled “Software Platform to Stratify Patients for Treatment Arm Randomization in Human Clinical Trials using Patient-Level Predictive Models” will be performed as a collaboration between Origent and Dr. Lorne Zinman, Associate Professor of Neurology at the University of Toronto Sunnybrook Health Sciences Centre. This project seeks to develop a prototype to test the use of patient disease progression predictions made by machine learning models as a new way of randomizing clinical trials. The prototype will serve as a platform for the inclusion of a range of drug development tools based on individual patient predictions.
This marks Origent’s second NIH SBIR award. Origent’s Chief Science Officer Dr. David L. Ennist will be the primary investigator for this project.